LONDON, England (AP) --An epilepsy drug offers significant promise in
helping alcoholics quit drinking and appears to be more effective than drugs now
in use for the problem, a new study shows.
Half of the 55 alcoholics who took the anti-seizure drug topiramate either
quit drinking altogether or cut back their drinking sharply.
Researchers found that those given the medication were six times more likely
than those on a dummy pill to abstain from alcohol for a month, according to the
report published Friday in The Lancet.
"This finding is a major scientific advance in the treatment of alcoholism,"
said Dr. Domenic Ciraulo, head of phsychiatry at Boston University, who was not
connected with the research.
Three drugs are now available worldwide for combatting alcoholism. One of
them, disulfiram, sold as Antabuse, makes people feel sick when they drink.
"The problem with that drug is that people know that if you want to drink,
all you have to do is throw the tablet away. It is not a treatment. All it does
is punish you for drinking," said Dr. Bankole Johnson, chief of alcohol and drug
addiction research at the University of Texas Health Science Center at San
Antonio and lead investigator in the latest study.
The other two drugs -- acamprosate, available in Europe but not the United
States, and naltrexone -- are given to ward off relapses once an alcoholic has
stopped drinking.
"What is good about topiramate is you can take it while you are still
drinking," Johnson said.
Scientists believe that the brain chemical dopamine is what provides the
pleasure from alcohol and that topiramate, sold as Topamax by Johnson & Johnson,
works by washing away the excess dopamine released by drinking alcohol.
Long-term studies in epileptic patients show no serious problems related to
topiramate.
'No magic bullet'
The study involved 103 hardcore alcoholics followed for three months. Many
had already tried methods such as Alcoholics Annonymous, medication,
psychotherapy and rehab clinics. When they enrolled in the study it had been at
least six months since they had been in treatment and they were drinking the
equivalent of two bottles of wine a day.
Fifty-five drinkers were given topiramate, while 48 were given a dummy pill.
The dose of topiramate was gradually increased.
All the participants got regular counseling to encourage them to keep taking
the drugs and refrain from drinking.
By the time the study ended, 13 out of the 55 in the topiramate group, or 24
percent, had abstained continuously for a month. That compares with two out of
48 people, or 4 percent, in the placebo group.
Alcoholism is a
complex disease and there's no
magic bullet out there. But just
to get a menu of different
treatments is a step in the
right direction.
-- Ray Litten
"This is continuous abstinence. This is the strictest way of looking at it.
You are not including people who may have had the odd drink," Johnson said.
The gap between the two groups was even wider when it came to binge drinking.
In the topiramate group, 28 out of 55, or 50 percent, did not binge in the
final month, compared with 8 out of 48, or 16 percent, of those taking the fake
pill. This means those taking the drug were nearly four times less likely to
binge.
In the topiramate group, reported cravings were cut in half, compared to a 15
percent drop in the placebo group.
Ray Litten, chief of treatment research at the U.S. National Institute on
Alcohol Abuse and Alcoholism, said topiramate could be a significant advance in
treating alcoholism.
"It does look like topiramate might be stronger than naltrexone or
acamprosate," Litten said. "It's very promising and it certainly has potential,
but this is only one study and more trials need to be done."
Litten said a combination of drugs and psychological therapy is considered
the best treatment.
"Alcoholism is a complex disease and there's no magic bullet out there,"
Litten said. "But just to get a menu of different treatments is a step in the
right direction."
Many experts say abstinence should still be the goal, but Johnson argues that
treatments that help alcoholics cut down -- say, from 10 drinks a day to two a
day -- is worthwhile.
"If you can make most people stop drinking at a hazardous level, you have
done them a power of good. You are going to improve these people's quality of
life, help save their marriages, their jobs," Johnson said.
Copyright 2003 The
Associated Press. All rights reserved. This material may not be
published, broadcast, rewritten, or redistributed.
DISCLAIMER: All
information, data, and material contained, presented, or provided here is for
general information purposes only and is not to be construed as reflecting the
knowledge or opinions of the publisher, and is not to be construed or intended
as providing medical or legal advice. The decision whether or not to vaccinate
is an important and complex issue and should be made by you, and you alone, in
consultation with your health care provider.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"